These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18850499)

  • 1. The relationship between the Dimensions of Change Instrument and retention in therapeutic community treatment: the moderating influence of time in treatment.
    Miles JN; Wenzel S; Mandell W
    Am J Drug Alcohol Abuse; 2008; 34(6):667-72. PubMed ID: 18850499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do dimensions of therapeutic community treatment predict retention and outcomes?
    Mandell W; Edelen MO; Wenzel SL; Dahl J; Ebener P
    J Subst Abuse Treat; 2008 Oct; 35(3):223-31. PubMed ID: 18248942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment process in the therapeutic community: associations with retention and outcomes among adolescent residential clients.
    Edelen MO; Tucker JS; Wenzel SL; Paddock SM; Ebener P; Dahl J; Mandell W
    J Subst Abuse Treat; 2007 Jun; 32(4):415-21. PubMed ID: 17481465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).
    Paddock SM; Edelen MO; Wenzel SL; Ebener P; Mandell W; Dahl J
    Am J Drug Alcohol Abuse; 2007; 33(4):537-46. PubMed ID: 17668339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further validity evidence for the dimensions of change in therapeutic community treatment instrument.
    Edelen MO; Miles JN; Osilla KC; Wenzel SL
    Am J Drug Alcohol Abuse; 2008; 34(3):285-92. PubMed ID: 18428071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The psychometric development and initial validation of the DCI-A short form for adolescent therapeutic community treatment process.
    Stucky BD; Edelen MO; Vaughan CA; Tucker JS; Butler J
    J Subst Abuse Treat; 2014 Apr; 46(4):516-21. PubMed ID: 24462245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of 3-month retention in a drug treatment therapeutic community.
    Mulder RT; Frampton CM; Peka H; Hampton G; Marsters T
    Drug Alcohol Rev; 2009 Jul; 28(4):366-71. PubMed ID: 19594790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention, early dropout and treatment completion among therapeutic community admissions.
    Darke S; Campbell G; Popple G
    Drug Alcohol Rev; 2012 Jan; 31(1):64-71. PubMed ID: 21426420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescents in therapeutic communities: retention and posttreatment outcome.
    Pompi KF
    NIDA Res Monogr; 1994; 144():128-61. PubMed ID: 8742609
    [No Abstract]   [Full Text] [Related]  

  • 11. Mindfulness-based stress reduction in therapeutic community treatment: a stage 1 trial.
    Marcus MT; Schmitz J; Moeller G; Liehr P; Cron SG; Swank P; Bankston S; Carroll DD; Granmayeh LK
    Am J Drug Alcohol Abuse; 2009; 35(2):103-8. PubMed ID: 19322731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the early therapeutic alliance in predicting drug treatment dropout.
    Meier PS; Donmall MC; McElduff P; Barrowclough C; Heller RF
    Drug Alcohol Depend; 2006 Jun; 83(1):57-64. PubMed ID: 16298088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed and dynamic predictors of client retention in therapeutic communities.
    Condelli WS; De Leon G
    J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personality disorders and retention in a therapeutic community for substance dependence.
    Samuel DB; LaPaglia DM; Maccarelli LM; Moore BA; Ball SA
    Am J Addict; 2011; 20(6):555-62. PubMed ID: 21999502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and treatment outcomes of perceived ward atmosphere among therapeutic community residents.
    Carr WA; Ball SA
    J Subst Abuse Treat; 2014; 46(5):567-73. PubMed ID: 24560437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How important are client characteristics to understanding treatment process in the therapeutic community?
    Chan KS; Wenzel S; Orlando M; Montagnet C; Mandell W; Becker K; Ebener P
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):871-91. PubMed ID: 15624553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting attrition in long-term residential substance use disorder treatment: A modifiable risk factors perspective.
    Baker DE; Edmonds KA; Calvert ML; Sanders SM; Bridges AJ; Rhea MA; Kosloff S
    Psychol Serv; 2020 Nov; 17(4):472-482. PubMed ID: 30816739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distance traveled to outpatient drug treatment and client retention.
    Beardsley K; Wish ED; Fitzelle DB; O'Grady K; Arria AM
    J Subst Abuse Treat; 2003 Dec; 25(4):279-85. PubMed ID: 14693257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual abuse, parental bonding, social support, and program retention for women in substance abuse treatment.
    Cosden M; Cortez-Ison E
    J Subst Abuse Treat; 1999 Mar; 16(2):149-55. PubMed ID: 10023613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.